Stephens Reaffirms “Overweight” Rating for XPO (NYSE:XPO)

Stephens reaffirmed their overweight rating on shares of XPO (NYSE:XPO – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. Stephens currently has a $150.00 price objective on the transportation company’s stock. A number of other research analysts have also recently commented on XPO. Barclays boosted their price target on […]

Leave a Reply

Your email address will not be published.

Previous post Valvoline (NYSE:VVV) Given “Outperform” Rating at Royal Bank of Canada
Next post Comparing iTeos Therapeutics (NASDAQ:ITOS) & Century Therapeutics (NASDAQ:IPSC)